OPINION: Time for Congress to Look at the Real Drivers of Health Costs

No one should have to put a price tag on their life.

In 2014, I was diagnosed with a rare but aggressive form of leukemia called acute myeloid leukemia. According to the New England Journal of Medicine, in people over 60, the survival rate is only 5 to 15 percent, and I am over 60. Besides that, because I had a rare and complicated case, my treatment cost a lot more than average.

Read full post at:

About the author

Kuldip K. Ahluwalia is a corporate and health-care industry veteran who has spent the past four years learning about the industry from a patient’s perspective. His background includes clinical research and developing and commercializing digital health and medical technology. He holds an M.S. in BioRadiology from UC, Berkely and a BSc (Hons) from the University of Salford (UK).